Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
First Psychedelic Drug for Depression Nears FDA Approval
Research & Development First Psychedelic Drug for Depression Nears FDA Approval

With a major breakthrough in psychedelic medicine, Compass Pathways' psilocybin-based therapy, COMP360, has delivered compelling Phase 3 results, sending shockwaves through the biopharma world and reigniting hope for patients with treatment-resistant depression. To unpack what this means for

Study Reveals Widening Disparities in Early Gastric Cancer
Research & Development Study Reveals Widening Disparities in Early Gastric Cancer

A comprehensive global analysis has uncovered a troubling paradox in the fight against early-onset gastric cancer, a form of the disease striking individuals under the age of 50. While worldwide mortality rates have been steadily decreasing for decades, this positive trend masks a deepening and

New Immune Discovery May Reverse Type 2 Diabetes
Research & Development New Immune Discovery May Reverse Type 2 Diabetes

A groundbreaking study from the University of Pittsburgh School of Medicine has illuminated a previously unknown immunological pathway that could fundamentally change how type 2 diabetes is treated, potentially offering a way to reverse the condition. As millions grapple with this chronic disease,

New Drug Combo May Defeat Ovarian Cancer Resistance
Research & Development New Drug Combo May Defeat Ovarian Cancer Resistance

The battle against cancer is often depicted as a prolonged war of attrition, where treatments gradually weaken a tumor over time until it finally succumbs. But new research is uncovering a startling truth about ovarian cancer: the enemy’s most sophisticated defense shield may deploy the moment the

New Alzheimer's Blood Test Validated in Latin America
Tech & Innovation New Alzheimer's Blood Test Validated in Latin America

A landmark multinational study has successfully validated a blood test for diagnosing Alzheimer’s disease and frontotemporal lobar degeneration within diverse Latin American populations, addressing a critical disparity in dementia diagnostics. Historically, the science behind these promising blood

AI Detects Heart Valve Disease Years Earlier
Tech & Innovation AI Detects Heart Valve Disease Years Earlier

We are joined today by Ivan Kairatov, a biopharma expert at the forefront of medical technology and innovation. We will be exploring a groundbreaking AI-powered tool that promises to transform the early detection of heart valve disease, a condition often called a "silent epidemic." Our conversation

ASH Issues New Guidelines for Young Adult Leukemia
Research & Development ASH Issues New Guidelines for Young Adult Leukemia

The landscape of hematology is undergoing a significant transformation, driven by a new consensus that seeks to correct decades of suboptimal outcomes for a frequently overlooked demographic caught between two distinct worlds of medical care. For years, adolescents and young adults (AYAs) diagnosed

Are Heart Meds Enough Without a Healthy Diet?
Research & Development Are Heart Meds Enough Without a Healthy Diet?

The quiet confidence that comes with taking a daily pill to manage cholesterol or blood pressure often masks a dangerous misconception that its protective shield is impenetrable, regardless of what one eats. This belief, however, is being challenged by rigorous scientific inquiry, forcing a

Emotional Pain, Not Fear, Defines Most PTSD
Tech & Innovation Emotional Pain, Not Fear, Defines Most PTSD

The quiet aftermath of a traumatic event often conjures images of panicked awakenings and a constant state of high alert, yet for the vast majority of survivors, the most debilitating struggle is a silent, internal battle waged not against terror but against a crushing weight of sorrow and

Why Did South Dakota Choose a Pause Over a Ban?
Biotech & Bioprocessing Why Did South Dakota Choose a Pause Over a Ban?

The emergence of cell-cultured protein has sparked intense debate at the intersection of agricultural tradition and technological innovation, nowhere more so than in states with deep roots in the livestock industry. In South Dakota, a legislative effort to completely prohibit the sale of lab-grown

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later